View Mobile No.

our range
2 results found for ""
Velpanat Tablets

Velpanat Tablets

Rs 10,990  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

BrandVelpanat
UsesHep C
Drug NameVelpanat
TreatmentHepatitis C virus infection (HCV)
Prescription/Non prescriptionPrescription
Dose/Strength (ex. 1 mg or 1 ml)100 mg/400 mg
Dosage FormTablet
UsageHospital,Clinical
Dose/Strength400mg & 100mg
Packaging Size28 Tablets
Packaging TypeBottle
ManufacturerNatco Pharma Ltd
FormTablet
Active IngredientSofosbuvir & Velpatasvir
CompositionSofosbuvir & velpatasvir
IndicationsHep C
Manufactured ByNatco
Marketed ByNatco
StrengthSofosbuvir 400mg & Velpatasvir 100mg

We are manfacturer,trader & supplier of  Velpanat tablet. Velpanat is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Velpanat is the FDA approved product, which is used in chronic HCV condition. Velpanat should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.

DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Velpanat tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Velpanat; The usual recommended dose of Velpanat is, one tablet should be administered orally as a single dose. Velpanat tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir

WORKS

 

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process.
UNFAVORABLE EFFECTS 

Serious bradycardia occurs due to concomitant use of Velpanat with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

LAB ABNORMALITIES

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

POST MARKETING EFFECTS

Cardiac disorders Rashes Angioedema

Velpanat Tablet Manufactured & Marketed By Natco Pharma Ltd

View Complete details

get quoterequest a call back
Velakast Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Velakast Tablets Sofosbuvir 400mg & Velpatasvir 100mg

Rs 8,200  / BottleGet Best Price

Minimum Order Quantity: 1 Bottle

Strength400mg/100mg
CompositionSofosbuvir 400mg & Velpatasvir 100mg
TreatmentHepatitis C virus infection (HCV)
Prescription/Non prescriptionPrescription
Packaging Size1x28
BrandVelakast
ManufacturerNatco Pharma Limited
FormTablet
Shelf life2 years
Therapeutic UsesHepatitis C virus infection (HCV)
We are manfacturer,trader & supplier of Velakast Tablets. Velakast tablet contains Sofosbuvir 400mg & Velpatasvir 100mg is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Velakast is the FDA approved product, which is used in chronic HCV condition. Velakast should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections. is the FDA approved product, which is used in chronic HCV condition. Velakast should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.
DOSAGE BEFORE THE TREATMENT

Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Velakast tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Velpanat; The usual recommended dose of Velakast  is, one tablet should be administered orally as a single dose. Velakast  tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir

WORKS

 

Sofosbuvir is a NS5B protein inhibitor, protein is essential for viral production. Sofosbuvir is a prodrug form, which get converted into active uridine triphosphate form which is required for anti-viral activity. This dynamic active moiety is get inserted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically acts as NS5A inhibitor; this protein is required for HCV viral production. Velpatasvir is involved its action in viral production process.
VELAKAST UNFAVORABLE EFFECTS 

Serious bradycardia occurs due to concomitant use of Velakast with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

LAB ABNORMALITIES

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

POST MARKETING EFFECTS

Cardiac disorders Rashes Angioedema

View Complete details

get quoterequest a call back

EXPLORE MORE CATEGORIES